A new study finds that following antiretroviral therapy for HIV, latent HIV cells only awake once a week, rather than the four to five times a week previously suggested.
Despite many setbacks in the road to developing an effective HIV vaccine, Johnson & Johnson report success in animal trials of their latest attempt.
A new study led by scientists at Beth Israel Deaconess Medical Center (BIDMC) shows that an HIV-1 vaccine regimen, involving a viral vector boosted with a purified envelope protein, provided complete...
A new article in Clinical Investigation highlights the learnings gleaned from monitoring several complex HIV clinical trials in Africa over a 15 year period.
HIV, or human immunodeficiency virus, is the retrovirus that leads to acquired immunodeficiency syndrome or AIDS.
Following a regional initiative to eliminate mother-to-child transmission of HIV and syphilis, Cuba becomes the first country to receive WHO validation for reaching the goal.
Researchers estimates pupils receiving an extra year of secondary school had an 8 percentage point lower risk of HIV infection a decade later than those that did not.
A new report states that unless efforts to stop new HIV infections and improve access to treatment improve over the next 5 years, deaths from AIDS and HIV infections will increase.
In New England Journal of Medicine, two experts make case for lifting federal funding bans for such programs to protect health of IV drug usersCongress needs to immediately lift the ban on...
Research published in the Proceedings of the National Academy of Sciences found that some individuals exposed to HIV-1, but who remain uninfected, have a certain pattern of virus-specific immune...
New UCLA research offers further evidence that cocaine use disrupts the immune system, making people who use it more likely to become infected with HIV.
A new paper out of the iPrEx study--a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men--reported no link...
Researchers at The Scripps Institute report preliminary success in designing a component for a potential HIV vaccine based on immunogens, rather than a deactivated virus.
The nature of HIV to mutate as soon as it enters its host has been a major frustration for HIV vaccine researchers.
The immune response could be guided, stepwise, to develop a special class of HIV-fighting antibodies, experiments suggestAs part of experiments intended to guide the immune system toward the...
Over 35 million people worldwide are currently infected by HIV. Antiviral therapies can keep the virus from multiplying.
New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine...
For the first time, researchers have identified two locations where slight differences in human immunodeficiency virus genetic code can change the way the virus infects cells.
The world invested more than $200 billion to improve health in lower-income countries over the past 15 years.
HIV testing in Coventry (UK) is to become a routine part of registering with a GP at ten surgeries across the city, which has the highest prevalence of the condition in the West Midlands.